219 related articles for article (PubMed ID: 20957396)
41. Inhibition of advanced glycation end-product formation on eye lens protein by rutin.
Muthenna P; Akileshwari C; Saraswat M; Bhanuprakash Reddy G
Br J Nutr; 2012 Apr; 107(7):941-9. PubMed ID: 21864418
[TBL] [Abstract][Full Text] [Related]
42. [Protein glycation--clinical and chemical aspects].
Szymańska U; Boratyński J
Postepy Hig Med Dosw; 1999; 53(5):689-703. PubMed ID: 10645144
[TBL] [Abstract][Full Text] [Related]
43. [Non-enzymatic glycosylation of proteins. Complications of diabetes mellitus, aging and kidney failure].
Monnier V
Presse Med; 1993 Oct; 22(30):1413-8. PubMed ID: 8248084
[TBL] [Abstract][Full Text] [Related]
44. [Oxidative stress and protein glycation in diabetes mellitus].
Gillery P
Ann Biol Clin (Paris); 2006; 64(4):309-14. PubMed ID: 16829472
[TBL] [Abstract][Full Text] [Related]
45. [Non-enzymatic glycation of proteins: from diabetes to cancer].
Ansari NA; Rasheed Z
Biomed Khim; 2010; 56(2):168-78. PubMed ID: 21341505
[TBL] [Abstract][Full Text] [Related]
46. LC-MS/MS analysis of carboxymethylated and carboxyethylated phosphatidylethanolamines in human erythrocytes and blood plasma.
Shoji N; Nakagawa K; Asai A; Fujita I; Hashiura A; Nakajima Y; Oikawa S; Miyazawa T
J Lipid Res; 2010 Aug; 51(8):2445-53. PubMed ID: 20386060
[TBL] [Abstract][Full Text] [Related]
47. Modification of proteins in vitro by physiological levels of glucose: pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions.
Voziyan PA; Khalifah RG; Thibaudeau C; Yildiz A; Jacob J; Serianni AS; Hudson BG
J Biol Chem; 2003 Nov; 278(47):46616-24. PubMed ID: 12975371
[TBL] [Abstract][Full Text] [Related]
48. The multifaceted therapeutic potential of benfotiamine.
Balakumar P; Rohilla A; Krishan P; Solairaj P; Thangathirupathi A
Pharmacol Res; 2010 Jun; 61(6):482-8. PubMed ID: 20188835
[TBL] [Abstract][Full Text] [Related]
49. [Glycation and protein crosslinking in the diabetes and ageing pathogenesis].
Cárdenas-León M; Díaz-Díaz E; Argüelles-Medina R; Sánchez-Canales P; Díaz-Sánchez V; Larrea F
Rev Invest Clin; 2009; 61(6):505-20. PubMed ID: 20184132
[TBL] [Abstract][Full Text] [Related]
50. Impairment of calcium ATPases by high glucose and potential pharmacological protection.
Horáková L; Strosova MK; Spickett CM; Blaskovic D
Free Radic Res; 2013 Aug; 47 Suppl 1():81-92. PubMed ID: 23710650
[TBL] [Abstract][Full Text] [Related]
51. Accumulation of fructosyl-lysine and advanced glycation end products in the kidney, retina and peripheral nerve of streptozotocin-induced diabetic rats.
Karachalias N; Babaei-Jadidi R; Ahmed N; Thornalley PJ
Biochem Soc Trans; 2003 Dec; 31(Pt 6):1423-5. PubMed ID: 14641079
[TBL] [Abstract][Full Text] [Related]
52. The fructosamine 3-kinase knockout mouse: a tool for testing the glycation hypothesis of intracellular protein damage in diabetes and aging.
Monnier VM
Biochem J; 2006 Oct; 399(2):e11-3. PubMed ID: 16987105
[TBL] [Abstract][Full Text] [Related]
53. Advanced glycosylation end products: a new disease marker for diabetes and aging.
Wu JT
J Clin Lab Anal; 1993; 7(5):252-5. PubMed ID: 8410484
[TBL] [Abstract][Full Text] [Related]
54. Role of early glycation Amadori products of lysine-rich proteins in the production of autoantibodies in diabetes type 2 patients.
Ansari NA; Moinuddin ; Mir AR; Habib S; Alam K; Ali A; Khan RH
Cell Biochem Biophys; 2014 Nov; 70(2):857-65. PubMed ID: 24789546
[TBL] [Abstract][Full Text] [Related]
55. [Atherosclerosis, alcohol and diabetes].
Bartos V
Vnitr Lek; 2002 Jun; 48(6):529-33. PubMed ID: 12132355
[TBL] [Abstract][Full Text] [Related]
56. Nonenzymatic glycation of collagen in aging and diabetes.
Reiser KM
Proc Soc Exp Biol Med; 1991 Jan; 196(1):17-29. PubMed ID: 1984239
[TBL] [Abstract][Full Text] [Related]
57. A review on prevention of glycation of proteins: Potential therapeutic substances to mitigate the severity of diabetes complications.
Sarmah S; Roy AS
Int J Biol Macromol; 2022 Jan; 195():565-588. PubMed ID: 34920073
[TBL] [Abstract][Full Text] [Related]
58. In vitro glycation and glycoxidation of phosphatidylethanolamines.
Annibal A; Fedorova M; Schiller J; Hoffmann R
Free Radic Biol Med; 2014 Oct; 75 Suppl 1():S21-2. PubMed ID: 26461306
[TBL] [Abstract][Full Text] [Related]
59. Pyridoxamine, an inhibitor of advanced glycation and lipoxidation reactions: a novel therapy for treatment of diabetic complications.
Metz TO; Alderson NL; Thorpe SR; Baynes JW
Arch Biochem Biophys; 2003 Nov; 419(1):41-9. PubMed ID: 14568007
[TBL] [Abstract][Full Text] [Related]
60. Chemical modification of proteins by lipids in diabetes.
Baynes JW
Clin Chem Lab Med; 2003 Sep; 41(9):1159-65. PubMed ID: 14598865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
